Literature DB >> 3015002

Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase.

A R Karlström, C F Källander, G Abele, A Larsson.   

Abstract

This study was performed to obtain information on the enzymatic background to the antiviral activity of acyclic guanosine analogs. Five acyclic guanosine analogs, the (R)- and (S)-enantiomers of 9-(3,4-dihydroxybutyl)guanine, 9-(4-hydroxybutyl)guanine, 9-[(2-hydroxyethoxy)methyl]guanine, and 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine, were compared in enzyme kinetic experiments using purified varicella-zoster virus and human placenta mitochondrial thymidine kinase (TK). All analogs showed competitive patterns of inhibition in the phosphorylation of thymidine by varicella-zoster virus TK, but only low affinities and phosphorylation rates were observed. No affinity for the mitochondrial TK was observed for any of the analogs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015002      PMCID: PMC180389          DOI: 10.1128/AAC.29.1.171

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Human deoxythymidine kinase. I. Purification and general properties of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia.

Authors:  L S Lee; Y C Cheng
Journal:  J Biol Chem       Date:  1976-05-10       Impact factor: 5.157

2.  An assay for pyrimidine deoxyribonucleoside kinase using gamma-32P-labeled ATP.

Authors:  M J Dobersen; S Greer
Journal:  Anal Biochem       Date:  1975-08       Impact factor: 3.365

3.  Properties of mitochondrial thymidine kinases of parental and enzyme-deficient HeLa cells.

Authors:  S Kit; W C Leung; D Trkula
Journal:  Arch Biochem Biophys       Date:  1973-10       Impact factor: 4.013

4.  Biochemical studies on the herpes simplex virus-specified deoxypyrimidine kinase activity.

Authors:  A T Jamieson; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

5.  Gel electrophoresis and isoelectric focusing of mitochondrial and viral-induced thymidine kinases.

Authors:  S Kit; W C Leung; D Trkula; G Jorgensen
Journal:  Int J Cancer       Date:  1974-02-15       Impact factor: 7.396

6.  Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities.

Authors:  P M Keller; J A Fyfe; L Beauchamp; C M Lubbers; P A Furman; H J Schaeffer; G B Elion
Journal:  Biochem Pharmacol       Date:  1981-11-15       Impact factor: 5.858

7.  Phosphorylation of four acyclic guanosine analogs by herpes simplex virus type 2 thymidine kinase.

Authors:  A Larsson; P Z Tao
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

8.  Bovid herpesvirus type-1 (infectious bovine rhinotracheitis virus)-induced thymidine kinase.

Authors:  G A Weinmaster; V Misra; R McGuire; L A Babiuk; E DeClercq
Journal:  Virology       Date:  1982-04-15       Impact factor: 3.616

9.  Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase.

Authors:  Y C Cheng; T Y Tsou; T Hackstadt; L P Mallavia
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

10.  Human serum antibodies to varicella-zoster virus thymidine kinase.

Authors:  C F Källander; J S Gronowitz; E G Torfason
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

View more
  6 in total

1.  Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture.

Authors:  G Abele; A Karlström; J Harmenberg; S Shigeta; A Larsson; B Lindborg; B Wahren
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

2.  Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA.

Authors:  A R Karlström; M Neumüller; J S Gronowitz; C F Källander
Journal:  Mol Cell Biochem       Date:  1990-01-18       Impact factor: 3.396

3.  Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate.

Authors:  G Abele; B Eriksson; J Harmenberg; B Wahren
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

4.  Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.

Authors:  Lianjuan Yang; Xiaohui Mo; Hong Yang; Hejun Dai; Fei Tan
Journal:  J Mol Model       Date:  2014-06-25       Impact factor: 1.810

5.  Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment.

Authors:  G B Roberts; J A Fyfe; R K Gaillard; S A Short
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.

Authors:  Chandrav De; Dongmei Liu; Bo Zheng; Uma S Singh; Satish Chavre; Catherine White; Robert D Arnold; Fred K Hagen; Chung K Chu; Jennifer F Moffat
Journal:  Antiviral Res       Date:  2014-07-19       Impact factor: 5.970

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.